AVP and depressive symptom measurement: Although AVP has not been thoroughly explored as a possible treatment target for addiction or psychiatric disorders, recent evidence suggests that this neuropeptide may be a promising target for stress-mediated depression and anxiety disorders [121-128], as well as have a role in the aversive effects of early withdrawal [61, 129, 130].